Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biological markers for the clinical diagnosis of Alzheimer's disease.

The Tohoku journal of experimental medicine - 1 Jun 1996

Arai H

Abstract excerpt

There is a compelling need to develop biological marker(s) to confirm a clinical diagnosis of Alzheimer's disease (AD) during life in order to unequivocally identify AD patients for emerging therapeutic interventions. This review describes recent advances in the development of diagnostic marker(s) for AD. They include polymorphism of apolipoprotein E (ApoE) and alpha 1-antichymotrypsin as well as cerebrospinal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alleles
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Amyloid beta-Peptides

Share to Apolipoproteins E

Share to Biomarkers

Share to tau Proteins

Source

Identifiers

PMID: 8875763
DOI: 10.1620/tjem.179.65

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biological markers for the clinical diagnosis of Alzheimer's disease.PMID 8875763Read ↗

Biomarkers for Alzheimer's disease.Semantic proximity Read ↗

Diagnostic approaches to Alzheimer's disease.Semantic proximity Read ↗

Genetic and biochemical markers for Alzheimer's disease: recent developments.Semantic proximity Read ↗

[Search of biological markers of Alzheimer's disease].Semantic proximity Read ↗

Marking the markers of Alzheimer's: too good to diagnose, too bad to use?Semantic proximity Read ↗

New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future.Semantic proximity Read ↗

Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease.Semantic proximity Read ↗

Biological markers for therapeutic trials in Alzheimer’s diseaseSemantic proximity Read ↗

Diagnosis of Alzheimer's disease: defining genetic profiles (genotype vs phenotype).Semantic proximity Read ↗

Early diagnosis of Alzheimer dementia based on clinical and biological factors.Semantic proximity Read ↗

CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.Semantic proximity Read ↗

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.